Literature DB >> 2331439

NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole.

L M Cobb1, T Hacker, J Nolan.   

Abstract

Hack and Helmy's method for the histochemical identification of NAD(P)H nitroblue tetrazolium reductase activity was employed to pinpoint reductase activity in certain cells in the mouse. High activity was observed in the following: lower airway epithelium, liver (centrilobular zone), eyelid (meibomian and sebaceous glands), vulval gland and parotid gland (striated cells of intralobular ducts). All of these cells had previously been identified as sites of binding of the reactive metabolites formed from the enzymic reduction of misonidazole (MISO) (Cobb et al., 1989). It had previously been thought that MISO binding would only take place in significant amounts in hypoxic tissues (tumour and possibly liver) since in normoxic tissues oxygen should reverse the initial one electron enzymic reduction, thus preventing progressive reduction to reactive species. We suggest that the very high levels of reductase in the above listed, probably normoxic, tissues contribute significantly to the accumulation of bound reactive MISO metabolite(s).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331439      PMCID: PMC1971377          DOI: 10.1038/bjc.1990.118

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  NADPH: cytochrome P-450 reductase in olfactory epithelium. Relevance to cytochrome P-450-dependent reactions.

Authors:  C J Reed; E A Lock; F De Matteis
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

2.  Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinomas.

Authors:  N A Schor; C J Cornelisse
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

3.  Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro.

Authors:  G G Miller; J Ngan-Lee; J D Chapman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982 Mar-Apr       Impact factor: 7.038

4.  Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.

Authors:  R C Urtasun; J D Chapman; J A Raleigh; A J Franko; C J Koch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

5.  Pharmacology and toxicology of sensitizers: mechanism studies.

Authors:  A M Rauth
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-08       Impact factor: 7.038

Review 6.  Misonidazole and other hypoxia markers: metabolism and applications.

Authors:  A J Franko
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

7.  The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.

Authors:  B M Garrecht; J D Chapman
Journal:  Br J Radiol       Date:  1983-10       Impact factor: 3.039

8.  Histochemical localization of NADP-dependent dehydrogenase activity with four different tetrazolium salts.

Authors:  C J Van Noorden; R G Butcher
Journal:  J Histochem Cytochem       Date:  1984-09       Impact factor: 2.479

9.  Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.

Authors:  A J Varghese; G F Whitmore
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.

Authors:  I J Stratford; P O'Neill; P W Sheldon; A R Silver; J M Walling; G E Adams
Journal:  Biochem Pharmacol       Date:  1986-01-01       Impact factor: 5.858

View more
  7 in total

1.  Hypoxia: A breath of fresh air for the meibomian gland.

Authors:  Yang Liu; Di Chen; Xiaomin Chen; Wendy R Kam; Mark P Hatton; David A Sullivan
Journal:  Ocul Surf       Date:  2018-12-04       Impact factor: 5.033

2.  Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.

Authors:  J M Cline; D E Thrall; R L Page; A J Franko; J A Raleigh
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

3.  Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.

Authors:  L M Cobb; J Nolan; S A Butler
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

4.  Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.

Authors:  M B Parliament; A J Franko; M J Allalunis-Turner; B W Mielke; C L Santos; B G Wolokoff; J R Mercer
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Corrective Rhinoplasty with Combined Use of Autogenous Auricular Cartilage and Porcine Dermal Collagen in Cleft Lip Nose Deformity.

Authors:  Young-Wook Park
Journal:  Maxillofac Plast Reconstr Surg       Date:  2014-09-30

6.  Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.

Authors:  M B Parliament; L I Wiebe; A J Franko
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver.

Authors:  G E Arteel; R G Thurman; J M Yates; J A Raleigh
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.